Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Validation of the High-Risk Prognostic Score Defined By the Presence of Mutations in NRAS or TP53 in a Cohort of 497 Patients with Acute Myeloid Leukemia

Rosa Ayala, MD PhD, Pau Montesinos, MD PhD, Eva Barragán, PhD, Joaquin Martinez-Lopez, MD, Miguel A. Sanz, Yanira Ruiz-Heredia, Santiago Barrio, Juan Manuel de la Rosa, Inmaculada Rapado, Pilar Martinez, MD, Rafael Colmenares, Maria Pozas, Xabier Gutierrez, María Luz Morales, Noemí Álvarez Sánchez-Redondo

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-137467

Published: 2020

Journal Articles

Differences in the Mutational Landscape of Myeloid Malignancies (acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasm) and Their Clinical Impact

María Poza, MD, Rafael Colmenares, MD, Alba González, Noemi Alvarez, Gonzalo Carreño Gomez-Tarragona, MD, Esther Onecha, PhD, María Teresa Cedena, MD, Pilar Martínez, MD, Juan Manuel de la Rosa, Inmaculada Rapado, PhD, Eva Barragán, PhD, Pau Montesinos, MD PhD, Rafael Llobet, Miguel Sanz, MD PhD, Joaquin Martinez-Lopez, MD PhD, Rosa Ayala, MD PhD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-141534

Published: 2020

Journal Articles

Clonal Hematopoiesis Landscape in Patients with De Novo Acute Myeloid Leukemia By Deep Sequencing

Blood (2016) 128 (22): 598.

https://doi.org/10.1182/blood.V128.22.598.598

Published: 2016

Journal Articles

Validation of a Next-Generation Sequencing Panel for AML Routine Diagnosis

Carmen M Alonso*, MD, Marta Llop*, PhD, Mariam Ibáñez, PhD, Jose Cervera, MD, Esperanza Such, PhD, Eva Villamon, Sarai Palanca, Inmaculada de Juan, Rosa Murria, Blanca de Unamuno, Laia Pedrola, Ivan Martin, Pau Montesinos, MD, Pascual Bolufer, Miguel A. Sanz, MD PhD, Eva Barragan, PhD

Blood (2015) 126 (23): 1403.

https://doi.org/10.1182/blood.V126.23.1403.1403

Published: 2015

Journal Articles

A Way to Individualized Therapy in Acute Myeloid Leukemia (AML): NGS Mutational Profile and Ex Vivo Pharmacological Test (Ex-viTech)

Esther Onecha, Joan Ballesteros, Jose L Rojas, Jose M Sanchez, Eva Barragan, PhD, Inmaculada Rapado, PhD, Santiago Barrio, David Martinez, MD PhD, Pau Montesinos, MD, Pilar Herrera, MD PhD, Carmen Burgaleta, MD, Joaquin Martinez-López, MDPhD, Rosa M. Ayala, MD PhD

Blood (2015) 126 (23): 1376.

https://doi.org/10.1182/blood.V126.23.1376.1376

Published: 2015

Journal Articles

Clinical Significance of Myelofibrotic (MF) Changes in Myelodysplastic Syndromes (MDS): A Prospective Evaluation Including Mutational Analysis By Next-Generation Sequencing (NGS)

Fernando Ramos, MDPhDMPH, Cristina Robledo, PhD, Francisco Miguel Izquierdo-García, MDPhD, Dimas Suárez-Vilela, MDPhD, Rocío Benito, PhD, Marta Fuertes, MDPhD, Andrés Insunza, MD, Eva Barragan, PhD, Mónica del Rey, PhD, José María García-Ruiz de Morales, MDPhD, Mar Tormo, MDPhD, Eduardo Salido, MDPhD, Lurdes Zamora, PhD, Carmen Pedro, MD, Javier Sánchez-del-Real, MD, María Díez-Campelo, MD PhD, Consuelo del Cañizo, MD PhD, Guillermo F. Sanz, MD PhD, Jesus Maria Hernández-Rivas, MDPhD

Blood (2014) 124 (21): 4652.

https://doi.org/10.1182/blood.V124.21.4652.4652

Published: 2014

Journal Articles

Wilms’ Tumor 1 Expression Levels in Bone Marrow after Induction and/or Consolidation Therapy Allow a Better Stratification of Patients and Improves Treatment in Adult AML

Blood (2014) 124 (21): 1036.

https://doi.org/10.1182/blood.V124.21.1036.1036

Published: 2014

Journal Articles

Gene Microdeletions in Adult and Pediatric Acute Lymphoblastic Leukemia,

Blood (2011) 118 (21): 3539.

https://doi.org/10.1182/blood.V118.21.3539.3539

Published: 2011

Journal Articles

Quantitative Expression Analysis of WT1 Main Isoforms in AML

Irene Luna, MD, Esperanza Such, Jose Cervera, MD, Eva Barragan, PhD, Marta Llop, Mariam Ibañez, Inés Gómez-Seguí, MD., Beatriz Costan, Oscar Fuster, PhD, Sandra Dolz, Federico Moscardo, MD, Pau Montesinos, MD, Maria López-Pavia, MD, David Martinez-Cuadrón, MD, Silvestre Oltra, Pascual Bolufer, Miguel A. Sanz, MD, PhD

Blood (2011) 118 (21): 1469.

https://doi.org/10.1182/blood.V118.21.1469.1469

Published: 2011

Journal Articles

Analysis of ASXL1, IDH1, IDH2, c-CBL , and WT1 Mutations in De Novo Acute Myeloid Leukaemia

Mariam Ibañez, Esperanza Such, Jose Cervera, MD, Irene Luna, MD, Sandra Dolz, Inés Gómez-Seguí, MD., Maria López-Pavia, MD, Beatriz Costan, Eva Barragan, PhD, Oscar Fuster, PhD, Marta Llop, Silvestre Oltra, Federico Moscardo, MD, Pau Montesinos, MD, David Martinez-Cuadrón, MD, Miguel A. Sanz, MD, PhD

Blood (2011) 118 (21): 1450.

https://doi.org/10.1182/blood.V118.21.1450.1450

Published: 2011

Journal Articles

SHP-1 (PTPN6) Gene Supression by FLT3/ITD Defines an Aggressive Subgroup of Myeloid Malignancies.

Armando V. Mena-Duran, MD, Juan C. Pajuelo, MSc, Jose Cervera-Zamora, MD, Zaida Garcia-Casado, PhD, Ana Valencia, MSc, Eva Barragan, PhD, Luis Benlloch, BSc, Tomas Mustelin, MD,PhD, Guillermo Sanz, MD,PhD, Miguel A. Sanz, MD,PhD

Blood (2006) 108 (11): 1907.

https://doi.org/10.1182/blood.V108.11.1907.1907

Published: 2006

NARROW

Validation of the High-Risk Prognostic Score Defined By the Presence of Mutations in NRAS or TP53 in a Cohort of 497 Patients with Acute Myeloid Leukemia

Differences in the Mutational Landscape of Myeloid Malignancies (acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasm) and Their Clinical Impact

Clonal Hematopoiesis Landscape in Patients with De Novo Acute Myeloid Leukemia By Deep Sequencing

Validation of a Next-Generation Sequencing Panel for AML Routine Diagnosis

A Way to Individualized Therapy in Acute Myeloid Leukemia (AML): NGS Mutational Profile and Ex Vivo Pharmacological Test (Ex-viTech)

Clinical Significance of Myelofibrotic (MF) Changes in Myelodysplastic Syndromes (MDS): A Prospective Evaluation Including Mutational Analysis By Next-Generation Sequencing (NGS)

Wilms’ Tumor 1 Expression Levels in Bone Marrow after Induction and/or Consolidation Therapy Allow a Better Stratification of Patients and Improves Treatment in Adult AML

Gene Microdeletions in Adult and Pediatric Acute Lymphoblastic Leukemia,

Quantitative Expression Analysis of WT1 Main Isoforms in AML

Analysis of ASXL1, IDH1, IDH2, c-CBL , and WT1 Mutations in De Novo Acute Myeloid Leukaemia

SHP-1 (PTPN6) Gene Supression by FLT3/ITD Defines an Aggressive Subgroup of Myeloid Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only